Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.46 |
| ▸ | PTGER3 | P43115 | 2/20 | 0.46 |
| ▸ | PTGER2 | P43116 | 2/20 | 0.46 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.41 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.41 |
| ▸ | TFEB | P19484 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | BCHE | P06276 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9402737 | 1.00 | HTT (0.48) | HTTPTGER4PTGER3PTGER2PTGER1 | |
| SCHEMBL9402728 | 1.00 | HTT (0.48) | HTTPTGER4PTGER3PTGER2PTGER1 | |
| SCHEMBL1082121 | 0.95 | HTT (0.50) | HTTPTGER4PTGER3PTGER2PTGER1 | |
| SCHEMBL5175460 | 0.89 | HTT (0.58) | HTTPTGER4PTGER3PTGER2PTGER1 | |
| SCHEMBL9402589 | 0.88 | KDM4E (0.42) | SMN1; SMN2KDM4ENFE2L2LMNAMAPT | |
| SCHEMBL9402597 | 0.88 | KDM4E (0.42) | SMN1; SMN2KDM4ENFE2L2LMNAMAPT | |
| SCHEMBL9402655 | 0.87 | LTB4R (0.38) | HTTPTGER4PTGER3PTGER2PTGER1 | |
| SCHEMBL9402666 | 0.87 | LTB4R (0.38) | HTTPTGER4PTGER3PTGER2PTGER1 | |
| Camphor SCHEMBL6143582 | 0.82 | MEN1 (0.37) | HTTPTGER4PTGER3PTGER2PTGER1 | |
| SCHEMBL9402798 | 0.82 | SMN1; SMN2 (0.36) | SMN1; SMN2KDM4ENFE2L2LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4748367-A2 | SUNSCREEN COMPOSITION | DSM IP Assets B.V. (NL) | 2026-05-27 | — | — | EP | claimed |
| EP-3357485-B1 | SUNSCREEN COSMETIC | SHISEIDO CO LTD (JP) | 2026-05-27 | — | — | EP | claimed |
| EP-4319884-B1 | COSMETIC COMPOSITION COMPRISING HINOKITIOL | UNILEVER IP HOLDINGS B V (NL) | 2026-05-27 | — | — | EP | claimed |
| EP-4568640-B1 | SUNSCREEN COMPOSITION | DSM IP ASSETS BV (NL) | 2026-05-13 | — | — | EP | claimed |
| US-12622861-B2 | Stable wash composition | CONOPCO, INC. (US) | 2026-05-12 | — | — | US | claimed |
| EP-4518849-B1 | COMPOSITION FOR TOPICAL APPLICATION FOR THE PHOTOTHERAPEUTIC TREATMENT OF INFLAMMATORY-BASED SKIN DISEASES | GIULIANI SPA (IT) | 2026-04-08 | — | — | EP | claimed |
| EP-4279532-B1 | CROSSLINKED POLYGLYCEROL PARTIAL ESTERS | EVONIK OPERATIONS GMBH (DE) | 2026-03-25 | — | — | EP | claimed |
| US-12582588-B2 | Solid cosmetic composition for blocking ultraviolet radiation having water resistance and cleansing properties | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2026-03-24 | — | — | US | claimed |
| EP-4648735-B1 | SUNSCREEN COMPOSITION WITH SPF BOOSTERS | GETTERS SPA (IT) | 2026-03-11 | — | — | EP | claimed |
| EP-4648734-B1 | SUNSCREEN COMPOSITION WITH FUNCTIONALIZED ZEOLITE SPF BOOSTERS | GETTERS SPA (IT) | 2026-02-18 | — | — | EP | claimed |
| EP-1341752-B1 | NOVEL INDANYLIDENE COMPOUNDS | SYMRISE GMBH & CO KG (DE) | 2004-08-04 | — | — | EP | claimed |
| WO-2004062635-A1 | COMPOSITIONS FOR SKIN LIGHTENING COMPRISING BIS-PANTOYL-CYSTAMINE | DSM IP ASSETS B.V. (NL) | 2004-07-29 | — | — | WO | claimed |
| EP-0996413-B1 | SUN PROTECTION COMPOSITION | COLGATE PALMOLIVE CO (US) | 2004-01-14 | — | — | EP | claimed |
| EP-1341752-A1 | NOVEL INDANYLIDENE COMPOUNDS | HAARMANN & REIMER GMBH (DE) | 2003-09-10 | — | — | EP | claimed |
| EP-1100432-A4 | NOVEL USES OF ASCORBYL-PHOSPHORYL-CHOLESTEROL AND COMPOSITIONS FOR PRACTICING SAME | AVON PROD INC (US) | 2003-06-04 | — | — | EP | claimed |
| US-6521668-B2 | For protection of keratinous tissue against environmental aggressors such as smoke, smog and UV radiation; contain as essential antioxidants hesperetin, tetrahydrocurcumin, tetrahydrodemethoxycurcumin | AVON PRODUCTS, INC. | 2003-02-18 | — | — | US | claimed |
| WO-2002038537-A1 | NOVEL INDANYLIDENE COMPOUNDS | HAARMANN & REIMER GMBH (DE) | 2002-05-16 | — | — | WO | claimed |
| EP-1100432-A1 | NOVEL USES OF ASCORBYL-PHOSPHORYL-CHOLESTEROL AND COMPOSITIONS FOR PRACTICING SAME | AVON PRODUCTS, INC. (US) | 2001-05-23 | — | — | EP | claimed |
| US-6162450-A | Uses of ascorbyl-phosphoryl-cholesterol and compositions for practicing same | AVON PRODUCTS, INC. (US) | 2000-12-19 | — | — | US | claimed |
| WO-2000006091-A1 | NOVEL USES OF ASCORBYL-PHOSPHORYL-CHOLESTEROL AND COMPOSITIONS FOR PRACTICING SAME | AVON PRODUCTS, INC. (US) | 2000-02-10 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622861-B2 | Stable wash composition | ALG1, IL4, CUTA | HTT 696/4885PTGER4 978/4885PTGER3 2478/4885 |
| US-12582588-B2 | Solid cosmetic composition for blocking ultraviolet radiation having water resistance and cleansing properties | CUTA, TRPA1, ERCC5 | HTT 3332/4885PTGER4 3670/4885PTGER3 3803/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.